Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen. Dong Z, Liu Z, Chen S, Zhang C, Xiao J, Zhou X. Nurs Open. 2021 Sep 30; doi: 10.1002/nop2.1059. Epub 2021 Sep 30. PMID: 34592784
Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From?. Battistoni A, Volpe M. Eur Cardiol. 2020 Apr 30;15:e21. doi: 10.15420/ecr.2019.21. eCollection 2020 Feb. PMID: 32419852
Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen. Dong Z, Liu Z, Chen S, Zhang C, Xiao J, Zhou X. Nurs Open. 2022 Jan;9(1):256-266. doi: 10.1002/nop2.1059. Epub 2021 Sep 30. PMID: 34592784
Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series. Goel M, Varandani RS, Okwuosa TM. Cardiooncology. 2020 Aug 27;6:15. doi: 10.1186/s40959-020-00071-x. eCollection 2020. PMID: 32864163
Prevalence of hypertension and pre-hypertension in the Middle East region: a systematic review & meta-analysis. Okati-Aliabad H, Ansari-Moghaddam A, Kargar S, Mohammadi M. J Hum Hypertens. 2022 Jan 15; doi: 10.1038/s41371-021-00647-9. Epub 2022 Jan 15. PMID: 35031669
Risk Factors of Breast Cancer in Hadramout Valley and Desert, Yemen. Bashamakha G, Bin Sumait H, Bashamakha M, Al Serouri A, Khader Y. Int J Prev Med. 2019 Oct 09;10:161. doi: 10.4103/ijpvm.IJPVM_251_17. eCollection 2019. PMID: 32133079
Berberine and cinnamaldehyde together prevent lung carcinogenesis. Meng M, Geng S, Du Z, Yao J, Zheng Y, Li Z, Zhang Z, Li J, Duan Y, Du G. Oncotarget. 2017 Aug 07;8(44):76385-76397. doi: 10.18632/oncotarget.20059. eCollection 2017 Sep 29. PMID: 29100319
Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen. Dong Z, Liu Z, Chen S, Zhang C, Xiao J, Zhou X. Nurs Open. 2022 Jan;9(1):256-266. doi: 10.1002/nop2.1059. Epub 2021 Sep 30. PMID: 34592784
